Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 123

    1.

    Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes.

    Pöykkö SM, Kellokoski E, Hörkkö S, Kauma H, Kesäniemi YA, Ukkola O.

    Diabetes. 2003 Oct;52(10):2546-53.PMID: 14514639 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Ghrelin Arg51Gln mutation is a risk factor for Type 2 diabetes and hypertension in a random sample of middle-aged subjects.

    Pöykkö S, Ukkola O, Kauma H, Savolainen MJ, Kesäniemi YA.

    Diabetologia. 2003 Apr;46(4):455-8. Epub 2003 Mar 14.PMID: 12739020 [PubMed - indexed for MEDLINE]Related articles

    3.

    The negative association between plasma ghrelin and IGF-I is modified by obesity, insulin resistance and type 2 diabetes.

    Pöykkö SM, Ukkola O, Kauma H, Kellokoski E, Hörkkö S, Kesäniemi YA.

    Diabetologia. 2005 Feb;48(2):309-16. Epub 2005 Feb 2.PMID: 15688209 [PubMed - indexed for MEDLINE]Related articles

    4.

    Leu7Pro polymorphism of PreproNPY associated with an increased risk for type II diabetes in middle-aged subjects.

    Ukkola O, Kesäniemi YA.

    Eur J Clin Nutr. 2007 Sep;61(9):1102-5. Epub 2007 Jan 31.PMID: 17268419 [PubMed - indexed for MEDLINE]Related articles

    5.

    The associations between plasma adiponectin, ghrelin levels and cardiovascular risk factors.

    Choi KM, Lee J, Lee KW, Seo JA, Oh JH, Kim SG, Kim NH, Choi DS, Baik SH.

    Eur J Endocrinol. 2004 May;150(5):715-8.PMID: 15132729 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.
    7.

    Circulating levels of active ghrelin is associated with abdominal adiposity, hyperinsulinemia and insulin resistance in patients with type 2 diabetes mellitus.

    Katsuki A, Urakawa H, Gabazza EC, Murashima S, Nakatani K, Togashi K, Yano Y, Adachi Y, Sumida Y.

    Eur J Endocrinol. 2004 Nov;151(5):573-7.PMID: 15538935 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Plasma ghrelin, body fat, insulin resistance, and smoking in clinically healthy men: the atherosclerosis and insulin resistance study.

    Fagerberg B, Hultén LM, Hulthe J.

    Metabolism. 2003 Nov;52(11):1460-3.PMID: 14624407 [PubMed - indexed for MEDLINE]Related articles

    9.

    Circulating obestatin levels in normal subjects and in patients with impaired glucose regulation and type 2 diabetes mellitus.

    Qi X, Li L, Yang G, Liu J, Li K, Tang Y, Liou H, Boden G.

    Clin Endocrinol (Oxf). 2007 Apr;66(4):593-7.PMID: 17371480 [PubMed - indexed for MEDLINE]Related articles

    10.

    Plasma ghrelin concentrations are decreased in insulin-resistant obese adults relative to equally obese insulin-sensitive controls.

    McLaughlin T, Abbasi F, Lamendola C, Frayo RS, Cummings DE.

    J Clin Endocrinol Metab. 2004 Apr;89(4):1630-5.PMID: 15070922 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Low ghrelin concentrations in nonalcoholic fatty liver disease are related to insulin resistance.

    Marchesini G, Pagotto U, Bugianesi E, De Iasio R, Manini R, Vanni E, Pasquali R, Melchionda N, Rizzetto M.

    J Clin Endocrinol Metab. 2003 Dec;88(12):5674-9.PMID: 14671152 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Role of ghrelin polymorphisms in obesity based on three different studies.

    Ukkola O, Ravussin E, Jacobson P, Pérusse L, Rankinen T, Tschöp M, Heiman ML, Leon AS, Rao DC, Skinner JS, Wilmore JH, Sjöström L, Bouchard C.

    Obes Res. 2002 Aug;10(8):782-91.PMID: 12181387 [PubMed - indexed for MEDLINE]Related articles

    13.

    Association of the Leu72Met polymorphism of the ghrelin gene with the risk of Type 2 diabetes in subjects with impaired glucose tolerance in the Finnish Diabetes Prevention Study.

    Mager U, Lindi V, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Tuomilehto J, Laakso M, Pulkkinen L, Uusitupa M; Finnish Diabetes Prevention Study Group.

    Diabet Med. 2006 Jun;23(6):685-9.PMID: 16759313 [PubMed - indexed for MEDLINE]Related articles

    14.

    Polymorphisms in the ghrelin gene are associated with serum high-density lipoprotein cholesterol level and not with type 2 diabetes mellitus in Koreans.

    Choi HJ, Cho YM, Moon MK, Choi HH, Shin HD, Jang HC, Kim SY, Lee HK, Park KS.

    J Clin Endocrinol Metab. 2006 Nov;91(11):4657-63. Epub 2006 Sep 5.PMID: 16954159 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Is HOMA index a predictor of nocturnal nondipping in hypertensives with newly diagnosed type 2 diabetes mellitus?

    Afsar B, Sezer S, Elsurer R, Ozdemir FN.

    Blood Press Monit. 2007 Jun;12(3):133-9.PMID: 17496462 [PubMed - indexed for MEDLINE]Related articles

    16.

    Is glycosylated hemoglobin A1c a surrogate for metabolic syndrome in nondiabetic, first-degree relatives of African-American patients with type 2 diabetes?

    Osei K, Rhinesmith S, Gaillard T, Schuster D.

    J Clin Endocrinol Metab. 2003 Oct;88(10):4596-601.PMID: 14557428 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Increase in adiponectin levels during pioglitazone therapy in relation to glucose control, insulin resistance as well as ghrelin and resistin levels.

    Otto C, Otto B, Göke B, Pfeiffer AF, Lehrke M, Vogeser M, Spranger J, Parhofer KG.

    J Endocrinol Invest. 2006 Mar;29(3):231-6.PMID: 16682836 [PubMed - indexed for MEDLINE]Related articles

    18.

    High normal 2-hour plasma glucose is associated with insulin sensitivity and secretion that may predispose to type 2 diabetes.

    Piché ME, Lemieux S, Pérusse L, Weisnagel SJ.

    Diabetologia. 2005 Apr;48(4):732-40. Epub 2005 Mar 12.PMID: 15765221 [PubMed - indexed for MEDLINE]Related articles

    19.

    Variants in the ghrelin gene are associated with metabolic syndrome in the Old Order Amish.

    Steinle NI, Pollin TI, O'Connell JR, Mitchell BD, Shuldiner AR.

    J Clin Endocrinol Metab. 2005 Dec;90(12):6672-7. Epub 2005 Oct 4.PMID: 16204371 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Plasma obestatin is lower at fasting and not suppressed by insulin in insulin-resistant humans.

    Anderwald-Stadler M, Krebs M, Promintzer M, Mandl M, Bischof MG, Nowotny P, Kästenbauer T, Luger A, Prager R, Anderwald C.

    Am J Physiol Endocrinol Metab. 2007 Nov;293(5):E1393-8. Epub 2007 Sep 4.PMID: 17785502 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data